FR5132M - - Google Patents

Info

Publication number
FR5132M
FR5132M FR46556A FR46556A FR5132M FR 5132 M FR5132 M FR 5132M FR 46556 A FR46556 A FR 46556A FR 46556 A FR46556 A FR 46556A FR 5132 M FR5132 M FR 5132M
Authority
FR
France
Prior art keywords
tablets
lysozyme
amylase
jan
suitably
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR46556A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR46556A priority Critical patent/FR5132M/fr
Priority to GB178567A priority patent/GB1171183A/en
Priority to BE692682D priority patent/BE692682A/xx
Application granted granted Critical
Publication of FR5132M publication Critical patent/FR5132M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats

Abstract

1,171,183. Compositions containing enzymes. CENTRE D'ETUDES POUR L'lNDUSTRIE PHARMACEUTIQUE. 12 Jan., 1967 [20 Jan., 1966], No. 1785/67. Heading A5B. Pharmaceutical compositions, having antiinflammatory and anti-oedematous activity, comprise a mixture of amylase and lysozyme (muramidase) together with a pharmaceutically acceptable vehicle. The amylase may be of bacterial, animal or vegetable origin, suitably being prepared from mushrooms. Lysozyme, which may be found in nasal mucus, saliva, tears, human milk or egg white, is suitably prepared from the latter, in aqueous solution, by absorption on bentonite, with elution of the enzyme with aqueous pyridine of pH 5.0, followed by precipitation with ammonium sulphate, dialysis and desiccation of the product. The compositions preferably also contain chymotrypsin, and mucopolysaccharidases (chondrosulphatase and hyaluronidase), or other depolymerising or hydrolytic enzymes. They may be in the forms for oral or topical administration, such as tablets, coated tablets, sublingual tablets, syrup, unit dosage packets, ointments, or spray solutions for use in an atomiser.
FR46556A 1966-01-20 1966-01-20 Expired FR5132M (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR46556A FR5132M (en) 1966-01-20 1966-01-20
GB178567A GB1171183A (en) 1966-01-20 1967-01-12 Pharmaceutical Compositions containing Enzymes
BE692682D BE692682A (en) 1966-01-20 1967-01-16

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR46556A FR5132M (en) 1966-01-20 1966-01-20

Publications (1)

Publication Number Publication Date
FR5132M true FR5132M (en) 1967-06-05

Family

ID=8599230

Family Applications (1)

Application Number Title Priority Date Filing Date
FR46556A Expired FR5132M (en) 1966-01-20 1966-01-20

Country Status (3)

Country Link
BE (1) BE692682A (en)
FR (1) FR5132M (en)
GB (1) GB1171183A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207288D0 (en) * 1992-04-02 1992-05-13 Unilever Plc Cosmetic composition
GB9207280D0 (en) * 1992-04-02 1992-05-13 Unilever Plc Skin care method and composition

Also Published As

Publication number Publication date
BE692682A (en) 1967-07-03
GB1171183A (en) 1969-11-19

Similar Documents

Publication Publication Date Title
US6017528A (en) Therapeutic treatment of group A streptococcal infections
IE812972L (en) Actaplanin derivatives
HUP9701437A2 (en) Use of complex lipides as stabilizing additives in pharmaceutical compositions containing digestive enzymes, pharmaceutical compns. and kits
ATE261494T1 (en) CONSTRUCTS FOR ADMINISTRATION OF THERAPEUTIC ACTIVE INGREDIENTS TO NEURON CELLS
Woollen et al. Studies on glucosaminidase. 6. N-Acetyl-β-glucosaminidase and N-acetyl-β-galactosaminidase activities of a variety of enzyme preparations
FR5132M (en)
GB1306264A (en)
ES2023727A6 (en) Pharmaceutical solution containing salbutamol and cromoglycic acid.
ATE218368T1 (en) MEDICATION CONTAINING PROTEIN C ACTIVATION PEPTIDE
ATE65914T1 (en) PHARMACEUTICALS CONTAINING PENTAMIDINE.
GB1196971A (en) Production of Fortified Sugar
GB1224281A (en) Process for purifying starch and purified starch and products containing same
GB1482651A (en) Pharmaceutical products
IE34609L (en) Therapeutic substituted thiazolidinedione
GB1235540A (en) Oral preparations containing proteolytic enzymes suitable for pediatric use
GB1182320A (en) Dihydroorotic and Salts
CA2046598A1 (en) T-pa solubilisation
IT1214915B (en) 4-METHOXYISOPHTALIC ACID DERIVATIVES WITH PHARMACOLOGICAL ACTIVITY IN THROMBOEMBOLIC DISORDERS AND PROCEDURE FOR ITS PREPARATION
IE34386L (en) Acetylsalicylic acid-containing composition
GB1313318A (en) Pharmaceutical preparation for the treatment of hemorrhoids
Rau et al. Influence of pH on the diastatic activity of fungal and malt amylases
IE35226B1 (en) Pharmaceutical preparations
GB851761A (en) Therapeutic compositions containing ferrous fumarate
Kemona et al. Blood serum lysozyme activity in rats following the acute intoxication with sodium salt of 2, 4-dichlorophenoxyacetic acid(2. 4-D)
GB1331734A (en) Quinidine alginate and process of preparation thereof